Literature DB >> 19286309

CXCR4 receptor positive spheroid forming cells are responsible for tumor invasion in vitro.

Alexander Krohn1, Yao-Hua Song, Fabian Muehlberg, Lilly Droll, Christoph Beckmann, Eckhard Alt.   

Abstract

Stem cells have been found to be involved in breast cancer growth, but the specific contribution of cancer stem cells in tumor biology, including metastasis, is still uncertain. We found that murine breast cancer cell lines 4T1, 4TO7, 167Farn and 67NR contains cancer stem cells defined by CXCR4 expression and their capability of forming spheroids in suspension culture. Importantly, we showed that CXCR4 expression is essential for tumor invasiveness because both CXCR4 neutralizing antibody and shRNA knockdown of the CXCR4 receptor significantly reduced tumor cell invasion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19286309     DOI: 10.1016/j.canlet.2009.02.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  23 in total

1.  Comparative analysis of chemokine receptor's expression in mesenchymal stem cells derived from human bone marrow and adipose tissue.

Authors:  Naghmeh Ahmadian Kia; Ahmad Reza Bahrami; Marzieh Ebrahimi; Maryam M Matin; Zeinab Neshati; Mahmood Rais Almohaddesin; Naser Aghdami; Hamid Reza Bidkhori
Journal:  J Mol Neurosci       Date:  2010-10-12       Impact factor: 3.444

2.  Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.

Authors:  Lyndsay V Rhodes; Sarah P Short; Nicole F Neel; Virgilio A Salvo; Yun Zhu; Steven Elliott; Yongkun Wei; Dihua Yu; Menghong Sun; Shannon E Muir; Juan P Fonseca; Melyssa R Bratton; Chris Segar; Syreeta L Tilghman; Tammy Sobolik-Delmaire; Linda W Horton; Snjezana Zaja-Milatovic; Bridgette M Collins-Burow; Scott Wadsworth; Barbara S Beckman; Charles E Wood; Suzanne A Fuqua; Kenneth P Nephew; Paul Dent; Rebecca A Worthylake; Tyler J Curiel; Mien-Chie Hung; Ann Richmond; Matthew E Burow
Journal:  Cancer Res       Date:  2010-12-01       Impact factor: 12.701

Review 3.  Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy.

Authors:  Geeta Mehta; Amy Y Hsiao; Marylou Ingram; Gary D Luker; Shuichi Takayama
Journal:  J Control Release       Date:  2012-05-18       Impact factor: 9.776

Review 4.  Metastatic cancer stem cells: from the concept to therapeutics.

Authors:  Wen-Ting Liao; Ya-Ping Ye; Yong-Jian Deng; Xiu-Wu Bian; Yan-Qing Ding
Journal:  Am J Stem Cells       Date:  2014-09-05

5.  Three-dimensional-engineered matrix to study cancer stem cells and tumorsphere formation: effect of matrix modulus.

Authors:  Xiaoming Yang; Samaneh K Sarvestani; Seyedsina Moeinzadeh; Xuezhong He; Esmaiel Jabbari
Journal:  Tissue Eng Part A       Date:  2012-11-07       Impact factor: 3.845

6.  Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells.

Authors:  Lyndsay V Rhodes; Melyssa R Bratton; Yun Zhu; Syreeta L Tilghman; Shannon E Muir; Virgilio A Salvo; Chandra R Tate; Steven Elliott; Kenneth P Nephew; Bridgette M Collins-Burow; Matthew E Burow
Journal:  Exp Cell Res       Date:  2011-08-30       Impact factor: 3.905

7.  Low-dose cisplatin-induced CXCR4 expression promotes proliferation of ovarian cancer stem-like cells.

Authors:  Yifei Chen; Shuying Wang; Shixia Bu; Minhua Xu; Dongmei Lai
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-01-26       Impact factor: 3.848

Review 8.  Circulating cancer stem cells: the importance to select.

Authors:  Ming-Hsin Yang; Ahmet Imrali; Christopher Heeschen
Journal:  Chin J Cancer Res       Date:  2015-10       Impact factor: 5.087

9.  Investigation of multicellular tumor spheroids enriched for a cancer stem cell phenotype.

Authors:  Tetiana Herheliuk; Olena Perepelytsina; Andriy Ugnivenko; Lyudmila Ostapchenko; Mykhailo Sydorenko
Journal:  Stem Cell Investig       Date:  2019-08-05

Review 10.  Role of CXCR4 in the progression and therapy of acute leukaemia.

Authors:  Long Su; Zheng Hu; Yong-Guang Yang
Journal:  Cell Prolif       Date:  2021-05-29       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.